Progesterone sensitive Interferon-γ producing cells detected by ELISpot assay in autoimmune progesterone dermatitis

A. Cristaudo, V. Bordignon, F. Palamara, M. De Rocco, M. Pietravalle, M. Picardo

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Autoimmune progesterone dermatitis (APD) is a rare cutaneous disorder, characterized by recurrent polymorphous cutaneous and mucosal manifestations. It is considered to be caused by a hypersensitive reaction to endogenous progesterone. However, in vitro T-cell activity to this hormone has been described in few patients. Here we report the case of a 30-year-old woman with recurrent pruritic erythematous, and erythema multiforme-like eruptions localized to the genital area. Positive cutaneous reaction to intradermal progesterone injection suggested the diagnosis of APD. The analysis of cellular immune response to progesterone, investigated by the ELISpot assay, showed a significantly higher level of Interferon-γ (IFN-γ) producing cells in this patient compared with a control group comprising five asymptomatic women in the luteal phase of the menstrual cycle. Our results suggest that the ELISpot technique, together with clinical evaluations and assessment of allergies, could be useful in the diagnosis of APD.

Original languageEnglish
Pages (from-to)439-441
Number of pages3
JournalClinical and Experimental Dermatology
Volume32
Issue number4
DOIs
Publication statusPublished - Jul 2007

Fingerprint

Interferons
Progesterone
Erythema Multiforme
Skin Manifestations
Intradermal Injections
Skin
Luteal Phase
Cellular Immunity
Hypersensitivity
Hormones
T-Lymphocytes
Control Groups
Autoimmune progesterone dermatitis
In Vitro Techniques

ASJC Scopus subject areas

  • Dermatology

Cite this

Progesterone sensitive Interferon-γ producing cells detected by ELISpot assay in autoimmune progesterone dermatitis. / Cristaudo, A.; Bordignon, V.; Palamara, F.; De Rocco, M.; Pietravalle, M.; Picardo, M.

In: Clinical and Experimental Dermatology, Vol. 32, No. 4, 07.2007, p. 439-441.

Research output: Contribution to journalArticle

@article{8d70fa6af54b470aa2f26a431b405b5f,
title = "Progesterone sensitive Interferon-γ producing cells detected by ELISpot assay in autoimmune progesterone dermatitis",
abstract = "Autoimmune progesterone dermatitis (APD) is a rare cutaneous disorder, characterized by recurrent polymorphous cutaneous and mucosal manifestations. It is considered to be caused by a hypersensitive reaction to endogenous progesterone. However, in vitro T-cell activity to this hormone has been described in few patients. Here we report the case of a 30-year-old woman with recurrent pruritic erythematous, and erythema multiforme-like eruptions localized to the genital area. Positive cutaneous reaction to intradermal progesterone injection suggested the diagnosis of APD. The analysis of cellular immune response to progesterone, investigated by the ELISpot assay, showed a significantly higher level of Interferon-γ (IFN-γ) producing cells in this patient compared with a control group comprising five asymptomatic women in the luteal phase of the menstrual cycle. Our results suggest that the ELISpot technique, together with clinical evaluations and assessment of allergies, could be useful in the diagnosis of APD.",
author = "A. Cristaudo and V. Bordignon and F. Palamara and {De Rocco}, M. and M. Pietravalle and M. Picardo",
year = "2007",
month = "7",
doi = "10.1111/j.1365-2230.2007.02382.x",
language = "English",
volume = "32",
pages = "439--441",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Progesterone sensitive Interferon-γ producing cells detected by ELISpot assay in autoimmune progesterone dermatitis

AU - Cristaudo, A.

AU - Bordignon, V.

AU - Palamara, F.

AU - De Rocco, M.

AU - Pietravalle, M.

AU - Picardo, M.

PY - 2007/7

Y1 - 2007/7

N2 - Autoimmune progesterone dermatitis (APD) is a rare cutaneous disorder, characterized by recurrent polymorphous cutaneous and mucosal manifestations. It is considered to be caused by a hypersensitive reaction to endogenous progesterone. However, in vitro T-cell activity to this hormone has been described in few patients. Here we report the case of a 30-year-old woman with recurrent pruritic erythematous, and erythema multiforme-like eruptions localized to the genital area. Positive cutaneous reaction to intradermal progesterone injection suggested the diagnosis of APD. The analysis of cellular immune response to progesterone, investigated by the ELISpot assay, showed a significantly higher level of Interferon-γ (IFN-γ) producing cells in this patient compared with a control group comprising five asymptomatic women in the luteal phase of the menstrual cycle. Our results suggest that the ELISpot technique, together with clinical evaluations and assessment of allergies, could be useful in the diagnosis of APD.

AB - Autoimmune progesterone dermatitis (APD) is a rare cutaneous disorder, characterized by recurrent polymorphous cutaneous and mucosal manifestations. It is considered to be caused by a hypersensitive reaction to endogenous progesterone. However, in vitro T-cell activity to this hormone has been described in few patients. Here we report the case of a 30-year-old woman with recurrent pruritic erythematous, and erythema multiforme-like eruptions localized to the genital area. Positive cutaneous reaction to intradermal progesterone injection suggested the diagnosis of APD. The analysis of cellular immune response to progesterone, investigated by the ELISpot assay, showed a significantly higher level of Interferon-γ (IFN-γ) producing cells in this patient compared with a control group comprising five asymptomatic women in the luteal phase of the menstrual cycle. Our results suggest that the ELISpot technique, together with clinical evaluations and assessment of allergies, could be useful in the diagnosis of APD.

UR - http://www.scopus.com/inward/record.url?scp=34249667165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249667165&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2230.2007.02382.x

DO - 10.1111/j.1365-2230.2007.02382.x

M3 - Article

C2 - 17362239

AN - SCOPUS:34249667165

VL - 32

SP - 439

EP - 441

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 4

ER -